期刊
NATURE REVIEWS CLINICAL ONCOLOGY
卷 7, 期 4, 页码 191-193出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrclinonc.2010.37
关键词
-
类别
Dose-dense administration of paclitaxel as well as intraperitoneal administration of platinum and paclitaxel as first-line treatments provide similar advantages compared with standard treatment in advanced ovarian cancer. Both approaches, however, need to be confirmed by additional studies. a low dose of pegylated liposomal doxorubicin combined with carboplatin is superior to standard paclitaxel and carboplatin in relapsed platinum-sensitive ovarian cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据